Novartis India Ltd.
NSE: NOVARTIND | BSE: 500672
₹1,181.30
₹-28.10
(-2.32%)
As on 18-May-2026 15:54IST
Market cap
₹2,935 Cr
Revenue (TTM)
₹354 Cr
P/E Ratio
31.5
P/B Ratio
3.6
Div. Yield
0 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹93 Cr
-
ROE
13.2 %
-
ROCE
17.2 %
-
Industry P/E
57.91
-
EV/EBITDA
17.1
-
Debt to Equity
0
-
Book Value
₹331.2
-
EPS
₹37.7
-
Face value
5
-
Shares outstanding
24,690,797
10 Years Aggregate
CFO
₹161.56 Cr
EBITDA
₹345.19 Cr
Net Profit
₹702.35 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Novartis India
| -- | -- | -- | -- | 18.8 | 13.1 | -- |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Novartis India
| -13.1 | 12.5 |
|
BSE Small Cap
| -1.8 | 62.8 |
|
BSE Healthcare
| -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Novartis India
|
1,181.3 | 2,935.0 | 354.3 | 93.2 | 26.0 | 11.7 | 31.5 | 3.6 |
| 2,799.1 | 23,046.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 64.7 | 13.9 | |
| 519.8 | 8,183.7 | 4,359.0 | 256.4 | 8.4 | 8.3 | 32.1 | 2.5 | |
| 724.4 | 14,152.5 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21 | 2.5 | |
| 428.1 | 16,146.3 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.1 | 4.1 | |
| 731.5 | 17,965.3 | 5,365.6 | 595.0 | 16.6 | 13.3 | 30.2 | 3.5 | |
| 1,811.3 | 21,167.1 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 175.1 | 23,095.7 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 466.3 | 18,730.3 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.1 | 3.9 | |
| 1,571.5 | 25,343.1 | 3,373.0 | 199.0 | 12.6 | 5.9 | 119 | 5.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Ashish Jain
About Novartis India
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and... Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. Read more
-
Incorporated
1947
-
Chairman
Christopher Snook
-
Managing Director
--
-
Group
Novartis India - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Novartis India Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Novartis India
What is the current share price of Novartis India Ltd Today?
The share price of Novartis India Ltd is ₹1,181.30 (NSE) and ₹1,180.50 (BSE) as of 18-May-2026 15:54 IST. Novartis India Ltd has given a return of 18.81% in the last 3 years.
What is the current PB & PE ratio of Novartis India Ltd?
The P/E ratio of Novartis India Ltd is 31.50 times as on 18-May-2026, a 46 discount to its peers’ median range of 57.91 times.
The P/B ratio of Novartis India Ltd is 3.59 times as on 18-May-2026, a 1 discount to its peers’ median range of 3.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.20
|
2.47
|
|
2024
|
29.80
|
3.41
|
|
2023
|
13.50
|
1.80
|
|
2022
|
0.00
|
2.10
|
|
2021
|
65.18
|
1.91
|
What is the 52 Week High and Low of Novartis India Ltd?
The 52-week high and low of Novartis India Ltd are Rs 1,275.00 and Rs 950.00 as of 18-May-2026.
What is the market cap of Novartis India Ltd?
Novartis India Ltd has a market capitalisation of ₹ 2,935 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Novartis India Ltd?
Before investing in Novartis India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.